
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
Amplify Seymour Cannabis ETF (CNBS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: CNBS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit -14.83% | Avg. Invested days 20 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 1.06 | 52 Weeks Range 13.96 - 40.80 | Updated Date 06/30/2025 |
52 Weeks Range 13.96 - 40.80 | Updated Date 06/30/2025 |
Upturn AI SWOT
Amplify Seymour Cannabis ETF
ETF Overview
Overview
The Amplify Seymour Cannabis ETF (CNBS) is an actively managed ETF focused on investing in companies that are expected to benefit from the growth of the legal cannabis and hemp industries. It aims to capitalize on the evolving global cannabis market through strategic stock selection.
Reputation and Reliability
Amplify ETFs is known for offering thematic ETFs, including several focused on innovative sectors. While relatively new, they are building a reputation for specialized investment products.
Management Expertise
The management team combines financial expertise with a deep understanding of the cannabis industry, leveraging insights from sector specialists and industry leaders.
Investment Objective
Goal
To seek long-term capital appreciation by investing in companies across the cannabis ecosystem.
Investment Approach and Strategy
Strategy: The ETF employs an active management strategy, selecting companies based on their potential to benefit from the cannabis and hemp industries' growth.
Composition The ETF primarily holds stocks of companies involved in cannabis cultivation, processing, distribution, retail, and related ancillary businesses. The fund may also invest in companies focused on cannabinoid-based pharmaceuticals.
Market Position
Market Share: Data is unavailable to compute an accurate market share, as precise market share data within the cannabis ETF sector fluctuates and often requires proprietary data sources.
Total Net Assets (AUM): 24683792.84
Competitors
Key Competitors
- AdvisorShares Pure Cannabis ETF (YOLO)
- ETFMG Alternative Harvest ETF (MJ)
- Global X Cannabis ETF (POTX)
- AdvisorShares Pure US Cannabis ETF (MSOS)
Competitive Landscape
The cannabis ETF market is highly competitive, with several players vying for market share. CNBS distinguishes itself through active management and a focus on companies aligned with Cy Seymour's insights. However, it faces stiff competition from larger, more established ETFs like MJ and MSOS, which have greater liquidity and brand recognition. Smaller AUM affects CNBS's competitive positioning, as it can impact trading volume and potential cost efficiencies.
Financial Performance
Historical Performance: Historical performance data should be obtained from official fund fact sheets or financial data providers for accurate numerical values.
Benchmark Comparison: A relevant benchmark for comparison could be a broad cannabis industry index, although there isn't a universally accepted standard. Comparing CNBS's performance against a blended index of its key holdings' sectors would also provide insights.
Expense Ratio: 0.75
Liquidity
Average Trading Volume
The average daily trading volume for CNBS is moderate, indicating a degree of liquidity though not as high as larger ETFs.
Bid-Ask Spread
The bid-ask spread for CNBS may vary depending on market conditions, but generally reflects the fund's liquidity and investor demand.
Market Dynamics
Market Environment Factors
CNBS's performance is influenced by factors like regulatory changes in the cannabis industry, evolving consumer preferences, and broader economic conditions affecting the market.
Growth Trajectory
The growth trajectory of CNBS depends on the expansion of legal cannabis markets globally, effective stock selection by the management team, and the fund's ability to adapt to market changes.
Moat and Competitive Advantages
Competitive Edge
CNBS's active management and association with Cy Seymour offer a perceived competitive edge, leveraging market insights and a proactive investment approach. This allows for flexibility in portfolio allocation based on current industry trends and emerging opportunities. The smaller size and focused approach potentially enable quicker responses to market changes than larger, passively managed competitors. This active strategy aims to identify undervalued companies and capitalize on growth catalysts within the cannabis sector.
Risk Analysis
Volatility
CNBS is expected to have high volatility due to the speculative nature of the cannabis industry and regulatory uncertainties.
Market Risk
The ETF is exposed to market risk associated with the cannabis industry, including regulatory changes, competition, and consumer demand fluctuations.
Investor Profile
Ideal Investor Profile
CNBS is suitable for investors with a high-risk tolerance who are seeking exposure to the potential growth of the cannabis industry.
Market Risk
CNBS is best suited for active traders or investors with a longer-term horizon and higher risk tolerance, seeking capital appreciation rather than passive index tracking.
Summary
The Amplify Seymour Cannabis ETF is an actively managed fund focused on the cannabis sector, aiming to generate capital appreciation. Its performance is tied to the legal cannabis industry's growth, facing risks from regulation and competition. CNBS's active management distinguishes it, but its size and market share are less than its larger competitors. Suitable for risk-tolerant investors seeking cannabis exposure, CNBS benefits from Cy Seymouru2019s insights and dynamic portfolio management.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Amplify ETFs website
- SEC Filings
- Various financial data providers (Yahoo Finance, Bloomberg)
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Investment decisions should be made based on individual circumstances and after consulting with a qualified financial advisor. Market data is subject to change and may not be entirely accurate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Amplify Seymour Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund"s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

